Eduardo Osinaga

3.0k total citations
83 papers, 2.3k citations indexed

About

Eduardo Osinaga is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eduardo Osinaga has authored 83 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 36 papers in Immunology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eduardo Osinaga's work include Glycosylation and Glycoproteins Research (46 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Galectins and Cancer Biology (24 papers). Eduardo Osinaga is often cited by papers focused on Glycosylation and Glycoproteins Research (46 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Galectins and Cancer Biology (24 papers). Eduardo Osinaga collaborates with scholars based in Uruguay, France and United States. Eduardo Osinaga's co-authors include Nora Berois, Teresa Freire, Daniel Mazal, Sylvie Bay, Luis Ubillos, Enrique Barrios, A Roseto, Andrea Medeiros, Gabriel A. Rabinovich and Carlos Carmona and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Eduardo Osinaga

81 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Osinaga Uruguay 29 1.5k 945 435 414 328 83 2.3k
John Pedersen Australia 34 1.6k 1.1× 439 0.5× 315 0.7× 752 1.8× 91 0.3× 90 3.6k
Dorothy Hudig United States 28 1.1k 0.7× 1.1k 1.2× 160 0.4× 518 1.3× 207 0.6× 79 2.4k
Tsui-Ling Hsu Taiwan 36 2.9k 1.9× 1.4k 1.5× 633 1.5× 509 1.2× 1.2k 3.6× 64 4.0k
Stephan von Gunten Switzerland 29 1.5k 1.0× 1.7k 1.8× 461 1.1× 284 0.7× 272 0.8× 73 3.0k
Otto Pritsch Uruguay 27 927 0.6× 873 0.9× 461 1.1× 154 0.4× 103 0.3× 71 2.2k
Fabio Dall’Olio Italy 35 2.7k 1.8× 1.5k 1.5× 553 1.3× 367 0.9× 607 1.9× 96 3.4k
M Matsumoto Japan 28 2.2k 1.5× 888 0.9× 309 0.7× 695 1.7× 225 0.7× 83 3.4k
Jacques Bara France 30 1.2k 0.8× 554 0.6× 507 1.2× 456 1.1× 241 0.7× 107 2.6k
Guillemette Huet France 34 1.7k 1.1× 717 0.8× 152 0.3× 643 1.6× 262 0.8× 67 2.9k
Peter L. Smith United States 23 1.2k 0.8× 1.2k 1.2× 253 0.6× 546 1.3× 263 0.8× 42 2.6k

Countries citing papers authored by Eduardo Osinaga

Since Specialization
Citations

This map shows the geographic impact of Eduardo Osinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Osinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Osinaga more than expected).

Fields of papers citing papers by Eduardo Osinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Osinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Osinaga. The network helps show where Eduardo Osinaga may publish in the future.

Co-authorship network of co-authors of Eduardo Osinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Osinaga. A scholar is included among the top collaborators of Eduardo Osinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Osinaga. Eduardo Osinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Freire, Teresa, María Fernanda García, Marcelo Fernández, et al.. (2024). Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors. Cancer Biotherapy and Radiopharmaceuticals. 39(5). 337–348.
3.
Russo, Sofía, Ignacio Cebrián, Álvaro W. Mombrú, et al.. (2024). Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity. International Journal of Biological Macromolecules. 279(Pt 3). 135327–135327. 1 indexed citations
4.
Vliet, Sandra J. van, Paula Carasi, Pablo Andrés García, et al.. (2021). The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2). Cancer Letters. 518. 72–81. 34 indexed citations
5.
Ubillos, Luis, et al.. (2018). Polypeptide‑GalNAc‑T6 expression predicts better overall survival in patients with colon cancer. Oncology Letters. 16(1). 225–234. 6 indexed citations
6.
Machado, Camila Maria Longo, Suely Nonogaki, Eduardo Osinaga, et al.. (2014). Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival. PLoS ONE. 9(11). e111592–e111592. 57 indexed citations
7.
Casas, Mariana, Pilar Moreno, Alfonso Cayota, et al.. (2013). GALNT11 as a new molecular marker in chronic lymphocytic leukemia. Gene. 533(1). 270–279. 20 indexed citations
8.
Dalotto‐Moreno, Tomás, Diego O. Croci, Juan P. Cerliani, et al.. (2012). Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease. Cancer Research. 73(3). 1107–1117. 216 indexed citations
9.
Hubert, Pascale, Sophie Viel, Nicolás André, et al.. (2011). Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy. Cancer Research. 71(15). 5134–5143. 100 indexed citations
10.
Medeiros, Andrea, María Laura Chiribao, Luis Ubillos, et al.. (2007). Mucin-type O-glycosylation in Mesocestoides vogae (syn. corti). International Journal for Parasitology. 38(3-4). 265–276. 8 indexed citations
11.
12.
Medeiros, Andrea, Nora Berois, Henia Balter, et al.. (2004). Monoclonal Antibodies against the Tn-Specific Isolectin B4 from Vicia villosa Seeds: Characterization of the Epitope of the Blocking Antibody VV34. PubMed. 23(1). 39–44. 1 indexed citations
13.
Osinaga, Eduardo, et al.. (2004). Surface Expression of Hsp25 and Hsp72 Differentially Regulates Tumor Growth and Metastasis. Tumor Biology. 25(5-6). 243–251. 76 indexed citations
14.
Berois, Nora, Leticia Zarantonelli, José Luis Rodríguez, et al.. (2002). Detection of bone marrow‐disseminated breast cancer cells using an RT‐PCR assay of MUC5B mRNA. International Journal of Cancer. 103(4). 550–555. 28 indexed citations
15.
Pritsch, Otto, Pablo Oppezzo, Renaud Du Pasquier, et al.. (1997). Molecular Cloning of a Monoclonal Anti-Tumor Antibody Specific for the Tn Antigen and Expression of an Active Single-Chain Fv Fragment. Hybridoma. 16(4). 317–324. 14 indexed citations
16.
Osinaga, Eduardo, et al.. (1992). Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma. Cancer. 69(7). 1745–1749. 5 indexed citations
17.
Pancino, Gianfranco, et al.. (1991). Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4. British Journal of Cancer. 63(3). 390–398. 30 indexed citations
18.
Pancino, Gianfranco, Marie‐Elisabeth Toubert, Eduardo Osinaga, et al.. (1991). Histological and urinary reactivity of monoclonal antibody 1be12 in bladder carcinoma. Purification of the antigen from urine. International Journal of Cancer. 47(2). 221–226. 3 indexed citations
19.
Pancino, Gianfranco, et al.. (1990). Production of a Monoclonal Antibody as Immunohistochemical Marker on Paraffin Embedded Tissues Using a New Immunization Method. Hybridoma. 9(4). 389–395. 34 indexed citations
20.
Pancino, Gianfranco, et al.. (1990). Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.. PubMed. 50(22). 7333–42. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Pedersen Breakdown of academic impact, for papers by Dorothy Hudig Breakdown of academic impact, for papers by Tsui-Ling Hsu Breakdown of academic impact, for papers by Stephan von Gunten Breakdown of academic impact, for papers by Otto Pritsch Breakdown of academic impact, for papers by Fabio Dall’Olio Breakdown of academic impact, for papers by M Matsumoto Breakdown of academic impact, for papers by Jacques Bara Breakdown of academic impact, for papers by Guillemette Huet Breakdown of academic impact, for papers by Peter L. Smith
Rankless by CCL
2026